Company Filing History:
Years Active: 2022-2025
Title: Sohrab Khan: Innovator in Adeno-Associated Virus Research
Introduction
Sohrab Khan is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of adeno-associated virus (AAV) antibodies. With a total of 2 patents, his work is paving the way for advancements in gene therapy and related applications.
Latest Patents
Sohrab Khan's latest patents include innovative research on adeno-associated virus antibodies and fragments thereof. The first patent focuses on an isolated anti-AAV antibody or an antigen-binding fragment capable of specifically binding to an epitope of the AAVrh74 capsid protein and its various uses. The second patent also pertains to isolated anti-AAV antibodies and fragments, emphasizing their potential applications in therapeutic settings.
Career Highlights
Sohrab Khan is currently employed at Sarepta Therapeutics, Inc., where he continues to push the boundaries of research in gene therapy. His work is instrumental in developing treatments that could significantly impact patients with genetic disorders.
Collaborations
Some of his notable coworkers include Danielle Griffin and Louise Rodino-Klapac, who contribute to the collaborative environment at Sarepta Therapeutics, Inc. Their combined expertise enhances the innovative efforts within the company.
Conclusion
Sohrab Khan's contributions to the field of biotechnology, particularly through his patents on adeno-associated virus antibodies, highlight his role as a key innovator. His work at Sarepta Therapeutics, Inc. continues to inspire advancements in gene therapy.